Kiniksa Pharmaceuticals, Ltd.
KNSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$43 | $14 | $183 | -$158 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $8 | -$34 | -$185 | $0 |
| Stock-Based Comp. | $31 | $27 | $25 | $25 |
| Change in WC | $25 | $1 | -$23 | $1 |
| Other Non-Cash | $4 | $2 | $3 | $3 |
| Operating Cash Flow | $26 | $13 | $6 | -$126 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$202 | -$205 | -$136 | -$157 |
| Inv. Sales/Matur. | $240 | $176 | $128 | $306 |
| Other Inv. Act. | $0 | $0 | $0 | -$20 |
| Investing Cash Flow | $38 | -$30 | -$8 | $129 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $3 | $0 |
| Stock Repurch. | -$5 | -$2 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $17 | $4 | -$1 | $6 |
| Financing Cash Flow | $12 | $1 | $3 | $6 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $76 | -$15 | $0 | $8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $108 | $123 | $122 | $114 |
| End Cash | $184 | $108 | $123 | $122 |
| Free Cash Flow | $25 | $13 | $6 | -$147 |